In pancreatic ductal adenocarcinoma, fibulin-5 promotes tumor progression by blocking reactive oxygen species production through competing with fibronectin for integrin binding sites, resulting in increased angiogenesis and tumor growth [123]. The gene discussed is FBLN5; the disease is pancreatic ductal adenocarcinoma.